What is Human?
Human is at the forefront of developing sophisticated wearable lower limb exoskeleton technology. Their innovative system is designed to support a full range of motion, enabling users to walk naturally and maintain balance across challenging terrains, including inclines, declines, and stairs. The core of their innovation lies in miniaturized, versatile robotic joint technology for the hip, knee, and ankle, protected by patent-pending mechanisms. This unique engineering positions Human's exoskeleton as a versatile solution applicable to a broad spectrum of industries, from mobility assistance and motion augmentation to robotic rehabilitation, the gaming industry, robotic surgery, and fall prevention.
How much funding has Human raised?
Human has raised a total of $10M across 1 funding round:
Series A
$10M
Series A (2023): $10M with participation from BENO Holding
Key Investors in Human
BENO Holding
BENO Holding is an entity focused on light industrial real estate, emphasizing user needs, sustainability, and long-term success. Their involvement suggests a strategic alignment with Human's operational or infrastructural growth, potentially supporting the company's expansion through real estate or operational investments.
What's next for Human?
The recent major strategic investment signals a pivotal growth phase for Human, likely enabling the company to scale its manufacturing capabilities, expand its research and development efforts, and broaden its market penetration. With a focus on enhancing human mobility and augmentation, this capital infusion is expected to accelerate the commercialization of their advanced exoskeleton system, potentially solidifying their market leadership in assistive robotics and motion enhancement technologies.
See full Human company page
